Admission Date:  [**2197-4-11**]              Discharge Date:   [**2197-4-17**]  Date of Birth:  [**2113-9-12**]             Sex:   F  Service: CARDIOTHORACIC  Allergies: Sulfa (Sulfonamide Antibiotics) / Hydralazine  Attending:[**First Name3 (LF) 922**] Chief Complaint: Aortic stenosis.
Major Surgical or Invasive Procedure: [**2197-4-11**] Aortic valve replacement with a 19-mm Magna Ease aortic valve bioprosthesis.
The patient was referred for aortic valve replacement.
Past Medical History: -ESRD secondary to Pauci-immune Crescentric Glomerulonephritis from Hydralazine, on HD since [**Month (only) 205**] (Tu, Th, Sa) -AFib, not on Coumadin -Hypertension -Hyperlipidemia -Aortic stenosis, severe -Steal syndrome from her AV fistula (L) -Gout -GERD -Age-related macular degeneration   Social History: -Lives alone, independent in most ADLs, but daughter assists with shopping and some meals -Tobacco: none -Alcohol: none -Illicits: none   Family History: -Father: died at 80 of "[**Last Name **] problem" -Mother: died at 89 of "something with her heart" -No history of rheumatologic illness, prostate, breast, ovarian, or colon cancer.
Physical Exam: Admission Physical Exam  Pulse:58 Resp:18  O2 sat:98/RA B/P  Right:144/66 Height:5'     Weight:128 lbs  General:NAD, alert, cooperative Skin: Dry [x] intact []multiple bruises, skin thin and fragile HEENT: PERRLA [x] EOMI [x] Neck:  Supple [x] Full ROM [x] Chest: Lungs clear bilaterally [x] Heart: RRR [x]  Irregular []  Murmur - II/VI SEM across precordium Abdomen: Soft [x] non-distended [x] non-tender [x]  bowel sounds + [x]well healed midline scar Extremities: Warm [ ], well-perfused [ ]  Edema Varicosities: None []venous changes ble Neuro: Grossly intact Pulses: Femoral      Right: +2  Left:+1 DP           Right:+2   Left:+1 PT           [**Name (NI) 167**]: +1  Left:+1 Radial       Right:+2   Left:+2  Carotid Bruit        Right/Left:murmur radiates to both carotids   Pertinent Results: [**2197-4-16**] Hct-31.5* [**2197-4-15**] WBC-5.8 RBC-3.54* Hgb-10.8* Hct-32.2* MCV-91 MCH-30.3 MCHC-33.4 RDW-17.1* Plt Ct-150 [**2197-4-11**] WBC-12.7*# RBC-3.25* Hgb-9.8* Hct-29.4* MCV-91 MCH-30.1 MCHC-33.2 RDW-18.6* Plt Ct-122* [**2197-4-16**] Glucose-146* UreaN-43* Creat-2.7* Na-138 K-3.9 Cl-98 HCO3-27 [**2197-4-11**] UreaN-28* Creat-2.4* Na-143 K-3.8 Cl-106 HCO3-30 AnGap-11 [**2197-4-16**] Calcium-8.4 Mg-2.0  [**2197-4-11**] MRSA SCREEN (Final [**2197-4-13**]):    No MRSA isolated.
Postbypass The patient is AV paced and is on a phenylephrine infusion.
CXR: [**2197-4-12**]: There has been interval removal of the right-sided chest tube with no evidence for pneumothorax.
Hemodialysis catheter and left internal jugular catheter are in unchanged positions.
IMPRESSION: Interval removal of right chest tube with no evidence for pneumothorax.
[**2197-4-17**] 06:05AM BLOOD Glucose-115* UreaN-54* Creat-2.9* Na-134 K-4.2 Cl-96 HCO3-27 AnGap-15  Brief Hospital Course: On [**2197-4-11**] Mrs [**Known lastname 1826**] was taken to the operating room and underwent  Aortic valve replacement with a 19-mm Magna Aortic valve bioprosthesis with Dr.[**Last Name (STitle) 914**].
Cardiopulmonary bypass time: 86 minutes.Cross clamp time:65 minutes.Please refer to operative report for further surgical details.
Overall the patient tolerated the procedure well and post-operatively was transferred to the CVICU in stable condition for recovery and invasive monitoring.
She was extubated, alert, oriented and breathing comfortably on 4L NC 98%.
The patient was neurologically intact and hemodynamically stable, weaned from inotropic and vasopressor support.
Chest tubes were discontinued without complication on POD #2.
Aggressive pulmonary toilet, nebs, incentive spirometer and ambulation were continued.
She was started on guaifenesin for a persistent non-productive cough.
Cardiac: pacing wires remained for a junctional rhythm until [**2197-4-16**] seen by Electrophysiology.
Epicardial wires discontinued per EP.
They re-evaluated her on [**2197-4-14**] and cleared her PO diet, thin liquids and soft consistency solids.
She was seen by physical  and occupational therapy for evaluation of strength and mobility.
Medications on Admission: AMLODIPINE 7.5 mg daily, B COMPLEX-VITAMIN C-FOLIC ACID 1 mg daily, FUROSEMIDE 40 mg daily, OMEPRAZOLE 40 mg daily, ONDANSETRON 4 mg by mouth every 8 hours as needed for nausea, SIMVASTIN 10 mg daily, ASPIRIN 325 mg daily, CALCIUM CARBONATE 260 mg (650 mg) twice a day   Discharge Medications: 1. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed for temperature >38.0.
2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
3. simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap PO DAILY (Daily).
5. heparin (porcine) 1,000 unit/mL Solution Sig: One (1) Injection PRN (as needed) as needed for line flush.
6. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
7. pantoprazole 40 mg Tablet, Delayed Release (E.C.)
8. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1)  Inhalation Q6H (every 6 hours).
9. guaifenesin 600 mg Tablet Extended Release Sig: One (1) Tablet Extended Release PO BID (2 times a day) as needed for cough.
Discharge Disposition: Extended Care  Facility: [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] at [**Doctor Last Name 5749**] [**Doctor Last Name **] Village  Discharge Diagnosis: ESRD secondary to Pauci-immune Crescentric Glomerulonephritis from hydralazine, on HD since [**Month (only) 205**] (Tu, Th, Sa) Paroxysmal AFib/Aflutter in [**8-6**] during acute renal failure, loculated pericardial effusion.
